![]() |
|
|
R Seifert, A Hoer, I Schwaner and A Buschauer
Institut fur Pharmakologie, Universitatsklinikum Rudolf Virchow, Freie Universitat Berlin, Germany.
Histamine H1 receptors mediate activation of phospholipase C, with subsequent increases in cytosolic Ca2+ concentration ([Ca2+]i), and H2 receptors mediate accumulation of cAMP. HL-60 promyelocytes possess H2 receptors, but it is not known whether these cells also possess H1 receptors. We studied the effects of histamine on [Ca2+]i and the functional importance of histamine receptors in HL-60 promyelocytes. In these cells, histamine and dimaprit increased [Ca2+]i with EC50 values of 15 microM and 30 microM, respectively. Diphenhydramine inhibited the effect of histamine (100 microM) on [Ca2+]i up to 40%, with an IC50 of 100 nM. Famotidine and cimetidine diminished the effect of histamine (100 microM) up to 75%, with IC50 values of 85 nM and 300 nM, respectively. Diphenhydramine plus famotidine abolished histamine- induced rises in [Ca2+]i. Impromidine, with an IC50 of 100 nM, abolished the effect of histamine (100 microM) on [Ca2+]i. Diphenhydramine, famotidine, cimetidine, and impromidine showed marked noncompetitive antagonism with histamine. Histamine-induced increases in [Ca2+]i were largely due to influx of Ca2+ from the extracellular space. Ca2+ influx was inhibited by 1-(beta-[3-(4- methoxyphenyl)propoxyl]-4-methoxyphenethyl)-1H-imida zole hydrochloride (SK&F 96365). Histamine activated phospholipase C. Histamine induced expression of formyl peptide receptors, which effect was abolished by famotidine. In U-937 promonocytes and in the human erythroleukemia cell lines HEL and K-562, histamine did not induce rises in [Ca2+]i. Our data suggest the following. (i) In HL-60 promyelocytes, histamine increases [Ca2+]i predominantly via H2 receptors and to a lesser extent via H1 receptors. (ii) The agonist/antagonist profile of the H2 receptor-mediated increases in [Ca2+]i differs markedly from that for cAMP accumulation, suggesting the involvement of different H2 receptor subtypes. (iii) In HL-60 promyelocytes, histamine activates nonselective cation channels and induces functional differentiation via H2 receptors.
This article has been cited by other articles:
![]() |
S.-X. Xie, P. Ghorai, Q.-Z. Ye, A. Buschauer, and R. Seifert Probing Ligand-Specific Histamine H1- and H2-Receptor Conformations with NG-Acylated Imidazolylpropylguanidines J. Pharmacol. Exp. Ther., April 1, 2006; 317(1): 139 - 146. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. T. Kelley, T. Burckstummer, K. Wenzel-Seifert, S. Dove, A. Buschauer, and R. Seifert Distinct Interaction of Human and Guinea Pig Histamine H2-Receptor with Guanidine-Type Agonists Mol. Pharmacol., December 1, 2001; 60(6): 1210 - 1225. [Abstract] [Full Text] [PDF] |
||||
![]() |
B.-C. Suh, H. Lee, D.-J. Jun, J.-S. Chun, J.-H. Lee, and K.-T. Kim Inhibition of H2 Histamine Receptor-Mediated Cation Channel Opening by Protein Kinase C in Human Promyelocytic Cells J. Immunol., August 1, 2001; 167(3): 1663 - 1671. [Abstract] [Full Text] [PDF] |
||||
![]() |
B.-C. Suh, H. Lee, I.-S. Lee, and K.-T. Kim Modulation of H2 histamine receptor-mediated cAMP generation and granulocytic differentiation by extracellular nucleotides via activation of protein kinase C J. Leukoc. Biol., January 1, 2001; 69(1): 169 - 176. [Abstract] [Full Text] |
||||
![]() |
J. Del Valle and I. Gantz Novel insights into histamine H2 receptor biology Am J Physiol Gastrointest Liver Physiol, November 1, 1997; 273(5): G987 - G996. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. J. Hill, C. R. Ganellin, H. Timmerman, J. C. Schwartz, N. P. Shankley, J. M. Young, W. Schunack, R. Levi, and H. L. Haas International Union of Pharmacology. XIII. Classification of Histamine Receptors Pharmacol. Rev., September 1, 1997; 49(3): 253 - 278. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Shayo, C. Davio, A. Brodsky, A. G. Mladovan, B. L. Legnazzi, E. Rivera, and A. Baldi Histamine Modulates the Expression of c-fos through Cyclic AMP Production via the H2 Receptor in the Human Promonocytic Cell Line U937 Mol. Pharmacol., June 1, 1997; 51(6): 983 - 990. [Abstract] [Full Text] |
||||